I studied it myself
In this CRS2.5 interface, the most N-terminal CCL1 residue K24 forms backboneside chain interactions with CCR8 residues E28 1.25 and H283 7.36 on the N-terminus and TM7, respectively, and side chainbackbone interactions with CCR8 residues Y94 2.63 and D97 2.66 on TM2 and ECL1, respectively
The amino acid sequence of the peptide itself is unchanged
It may be suitable for individuals with comorbid conditions like type 2 diabetes, hypertension, or dyslipidemia
Patients with a history of other thyroid conditionssuch as papillary thyroid cancer, follicular thyroid cancer, thyroid nodules, hypothyroidism, or hyperthyroidismare not contraindicated from receiving semaglutide based on thyroid history alone
This can increase weight cycling and frustration, and whats the plan if this happens to you